How does the 20x MediShield Life cancer drug multiplier translate into actual dollar coverage?

MediShield Life Cancer Drug Coverage Multiplier and Dollar Limits

The 20x multiplier for MediShield Life cancer drug coverage refers to the enhanced subsidy levels available for approved drugs under the Cancer Drug List (CDL), not a direct multiplier on your total annual coverage limit. The actual dollar coverage depends on the specific drug, the subsidy tier it falls under, and your Medisave usage limits.

Subsidy Tiers and Medisave Limits:

• Subsidised Drugs: For drugs on the CDL, subsidies range from 40% to 80% of the bill, depending on the drug's clinical efficacy and cost-effectiveness. The 20x multiplier relates to the enhanced subsidy framework introduced to ensure access to newer, more expensive treatments.
• Medisave Usage Limits: Your ability to pay for cancer treatments using Medisave is subject to annual limits:
• You can use Medisave for approved cancer drugs and related treatments up to $600 per month or $1,200 per month, depending on the specific treatment and whether you are on a subsidy tier (as per CPF Board guidelines).
• This means the maximum amount you can draw from your Medisave account annually for these treatments is $7,200 (if using the $600/month limit) or $14,400 (if using the $1,200/month limit).

Example of Dollar Coverage:

If a course of treatment costs SGD $10,000 and is eligible for an 80% subsidy, the bill is reduced to $2,000. You would pay the remaining $2,000, which can be covered by MediShield Life/Integrated Shield Plan, and then potentially paid using your Medisave up to the applicable monthly limit ($600 or $1,200).

It is crucial to note that the total amount payable from Medisave for cancer treatments is capped annually by these specific limits, separate from the general BHS (Basic Healthcare Sum) or premiums paid for MediShield Life/Integrated Shield Plan.